BioSig Expands Its Clinical Footprint In Florida

NEXT STORY
Kura Oncology Doses First Patient in Phase 1/2 Clinical Trial of Tipifarnib in Combination with Alpelisib in Head and Neck Squamous Cell Carcinoma
PREV STORY
GRSi Wins a Three-Year Contract to Provide Extramural Division Analysis and Environmental Assessment Support to NIDDK
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chembio Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021

author_avatar
NASDAQ Market News

Worldwide Generic Drugs Industry to 2026 – Players Include Mylan, Novartis and Pfizer Among Others

author_avatar
NASDAQ Market News

Translate Bio Appoints Robert Plenge, M.D., Ph.D., to its Board of Directors

author_avatar
NASDAQ Market News